CINGW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $0.01
Market Cap (MRQ) $70.9K
EPS $-4.44
ROE -559.8%
Debt/Equity (MRQ) 0.2
52W Range $0–$0

CINGW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
EPS$-4.44
2022-12-31 → 2025-12-31
Free Cash Flow$-17M
2021-12-31 → 2025-12-31
Net margin1649.4%
2025-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend CINGW 5Y avg Peer Median Verdict
P/B (MRQ) 0.0 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 12
Metric Trend 202520242023202220212020
R&D Expense $10M$9M$15M$9M$8M$5M
SG&A Expense $10M$6M$7M$9M$12M$2M
Operating Income $-20M$-16M$-23M$-18M$-21M$-7M
Interest Expense ··$790.0K$292.3K··
Other Non-op ·$99.2K$-775.8K$-174.5K$-30.6K$-100.3K
Pretax Income $-22M$-17M$-24M$-18M$-21M$-7M
Net Income $-22M$-17M$-24M$-18M$-21M$-7M
EPS (Basic) $-4.44$-10.86$-311.99$-29.35$-2.79·
EPS (Diluted) $-4.44$-10.86$-311.99$-29.35··
Shares (Basic) 5,055,3291,524,79775,435602,3407,413,579·
Shares (Diluted) 5,055,3291,524,79775,435602,340··
EBITDA $-20M$-16M$-23M$-18M$-21M·
Balance Sheet 24
Metric Trend 202520242023202220212020
Cash & Equivalents $11M$12M$52.4K$5M$16M$1M
Short-term Investments ····$933$933
Receivables ··$14.6K···
Prepaid Expense $1M$423.2K$511.6K$2M$2M$439.5K
Current Assets $12M$13M$578.6K$8M$19M$2M
PP&E (Net) $2M$2M$3M$3M$3M$3M
PP&E (Gross) $6M$5M$5M$5M$5M$4M
Accum. Depreciation $4M$3M$3M$2M$2M$957.7K
Total Assets $15M$15M$3M$11M$23M$6M
Accounts Payable $2M$1M$5M$762.4K$264.7K$975.1K
Accrued Liabilities $2M$1M$2M$894.6K$601.3K$1M
Short-term Debt $6M$3M$3M$5M·$500.3K
Current Liabilities $10M$5M$10M$7M$1M$3M
Capital Leases $1M·$130.7K$488.7K$828.5K$1M
Other Non-current Liabilities ·····$23.6K
Total Liabilities $13M$7M$10M$8M$2M$4M
Total Debt $6M$3M$3M$5M··
Common Stock $725$340$10$61$1.1K·
Paid-in Capital $135M$117M$86M$73M$73M·
Retained Earnings $-132M$-110M$-93M$-69M$-52M$-31M
AOCI ····$165$165
Stockholders' Equity $3M$7M$-7M$4M$21M$1M
Liabilities + Equity $15M$15M$3M$11M$23M$6M
Shares Outstanding 7,250,2993,402,30697,293602,64011,309,412·
Cash Flow 10
Metric Trend 202520242023202220212020
Stock-based Comp $2M$995.5K$812.7K$800.8K$43.8K·
Deferred Tax ···$0$0·
Operating Cash Flow $-17M$-18M$-15M$-16M$-10M$-7M
CapEx $162.1K$211.8K$224.1K$153.4K$814.7K$402.1K
Investing Cash Flow $-162.1K$-211.8K$-224.1K$-152.7K$-814.7K$-384.2K
Stock Issued $10M$26M$7M·$20M·
Net Stock Activity $10M$26M$7M·$20M·
Financing Cash Flow $16M$31M$10M$5M$27M$8M
Net Change in Cash $-1M$12M$-5M$-11M$15M·
Free Cash Flow $-17M$-19M$-15M$-16M$-11M·
Profitability 6
Metric Trend 202520242023202220212020
Operating Margin 1464.8%·····
Net Margin 1649.4%·····
Pretax Margin 1649.4%·····
EBITDA Margin 1464.8%·····
ROA -150.0%-169.4%-316.0%-103.1%-144.4%·
ROE -559.8%-159.5%675.7%-288.6%-173.1%·
Liquidity & Solvency 4
Metric Trend 202520242023202220212020
Current Ratio 1.22.50.11.116.0·
Quick Ratio 1.12.50.00.814.0·
Debt / Equity 2.50.3-0.41.3··
Interest Coverage ··-28.8-59.9··
Efficiency 1
Metric Trend 202520242023202220212020
Asset Turnover -0.1·····
Per Share 5
Metric Trend 202520242023202220212020
Book Value / Share $0.35$2.19$-5.88$0.34$1.84·
Revenue / Share $-0.27·····
Cash Flow / Share $-3.41$-12.10$-16.61···
Cash / Share $1.51$3.59$0.04$0.47$1.46·
EPS (TTM) $-4.44$-10.86$-311.99$-29.35··
Valuation (TTM) 2
Metric Trend 202520242023202220212020
Revenue TTM $-1M$99.2K····
Net Income TTM $-22M$-17M$-24M$-18M$-21M·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Operating Margin % 1464.8% · · · ·
Net Income $-22M $-17M $-24M $-18M $-21M
Diluted EPS $-4.44 $-10.86 $-311.99 $-29.35 ·

Institutional owners (13F) 8 filers · $2K total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 8
Value held $2K
New positions 6
Exited positions 2
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
6 (+4 vs prior Q) 2 (+1 vs prior Q) 1 (+1 vs prior Q) 0 (-1 vs prior Q) +94K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
CAPTRUST FINANCIAL ADVISORS $672 35,200 36.60% Shares
MAI Capital Management $497 26,021 27.07% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $441 23,080 24.02% Shares
TWO SIGMA SECURITIES, LLC $209 10,918 11.38% Shares
GoalVest Advisory LLC $15 3,000 0.82% Shares
TORONTO DOMINION BANK $2 100 0.11% Shares
HRT FINANCIAL LP $0 13,224 0.00% Shares
Virtu Financial LLC $0 12,626 0.00% Shares

Company insiders 12 insiders · 7 officers · 6 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Shane J. Schaffer Chief Executive Officer July 16, 2026 A · 0 0 $0
Jennifer L. Callahan EVP and CFO July 16, 2026 A · 0 0 $0
Laurie Myers EVP and COO July 7, 2025 A · 0 0 $0
Raul R. Silva EVP and CSO Sept. 30, 2026 A · 0 0 $0
Bryan Wade Downey EVP & Chief Commercial Officer July 16, 2026 A · 0 0 $0
Matthew Brams EVP and Chief Medical Officer July 16, 2026 A · 0 0 $0
Nilay Dahyabhai Patel CLO and CCO July 8, 2025 A · 0 0 $0
Bryan Jay Lawrence Director July 16, 2026 A · 0 0 $0
Peter J. Werth Director July 16, 2026 A · 0 0 $0
Thomas Jeffrey Hargroves Director July 16, 2026 A · 0 0 $0
Jeffrey S Ervin Director June 20, 2025 A · 0 0 $0
John A Roberts Director June 20, 2025 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 13, 2026